The seminar series from the Early Cancer Institute aims to connect researchers in the early cancer detection and diagnosis space to share knowledge and spark collaboration. Join fellow researchers for lunch and an opportunity to network.
On Tuesday 21st March we welcome Dr Raheleh Rahbari from the Wellcome Sanger Institute to speak on: Mutational landscape and clonal dynamics across normal tissues.
This event will take place in the Jeffrey Cheah Biomedical Centre lecture theatre.
Raheleh Rahbari is a Cancer Research UK Career Development Fellow, her research focuses on mutations acquired during ageing and how they can predispose to disease across generations. Raheleh gained her PhD in Medical Genetics at the University of Leicester. Following this she undertook a postdoctoral position at the Sanger Institute. In 2019 she successfully applied for a Career Development Fellowship from Cancer Research UK.
In 2022 she became a Group Leader at the Sanger Institute. Her group focuses on understanding the origin of mutations acquired during ageing in normal tissues, with an aim to provide insight into early stages of cancer transformation and disease predisposition.
Register for the event here: https://EarlyCancerSeminar_Raheleh_Rahbari.eventbrite.co.uk